Monte Rosa Therapeutics, Inc. (GLUE) is listed on NASDAQ in Biotech Stocks. It is $13.37, -6.63%, with a $1.1B market cap. RSI is 23.5, oversold. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 23.5 Oversold
Market Cap $1.1B
Volume 653.2K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-87.9M
EPS --
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Warmuth Markus | President & CEO | Sell | 9,500 | $23.18 | $220,219 | 2026 Jul 16 |
| Champoux Jennifer | Chief Operating Officer | Sell | 4,351 | $23.38 | $101,730 | 2026 Jul 15 |
| Townson Sharon | Chief Scientific Officer | Sell | 6,000 | $23.31 | $139,849 | 2026 Jul 6 |
| Janku Filip | Chief Medical Officer | Sell | 5,407 | $24.50 | $132,472 | 2026 Jun 30 |
| Janku Filip | Chief Medical Officer | Sell | 6,000 | $22.95 | $137,700 | 2026 Jun 29 |
| Manning Anthony M. | Insider | Sell | 10,000 | $23.11 | $231,100 | 2026 Jun 29 |
| Janku Filip | Chief Medical Officer | Sell | 41,845 | $21.08 | $882,203 | 2026 Jun 24 |
| Champoux Jennifer | Chief Operating Officer | Sell | 2,175 | $20.00 | $43,500 | 2026 Jun 23 |
| Townson Sharon | Chief Scientific Officer | Sell | 3,000 | $20.00 | $60,000 | 2026 Jun 23 |
| Champoux Jennifer | Chief Operating Officer | Sell | 2,176 | $19.00 | $41,344 | 2026 Jun 17 |
| Townson Sharon | Chief Scientific Officer | Sell | 3,000 | $19.00 | $57,000 | 2026 Jun 17 |
| Warmuth Markus | President & CEO | Sell | 5,466 | $19.44 | $106,253 | 2026 Jun 1 |
| Townson Sharon | Chief Scientific Officer | Sell | 6,000 | $19.87 | $119,220 | 2026 May 29 |
| Champoux Jennifer | Chief Operating Officer | Sell | 2,175 | $20.00 | $43,500 | 2026 May 27 |
| Champoux Jennifer | Chief Operating Officer | Sell | 2,176 | $19.00 | $41,344 | 2026 May 22 |
| Manning Anthony M. | Insider | Sell | 10,000 | $18.01 | $180,100 | 2026 May 21 |
| Warmuth Markus | President & CEO | Sell | 5,467 | $18.92 | $103,447 | 2026 May 1 |
| Warmuth Markus | President & CEO | Sell | 8,000 | $17.64 | $141,125 | 2026 Apr 14 |
| Nickson Philip | Chief Business & Legal Officer | Sell | 5,845 | $17.69 | $103,413 | 2026 Apr 9 |
| Dunn Edmund | Principal Accounting Officer | Sell | 139 | $17.96 | $2,496 | 2026 Mar 4 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
Take GLUE further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GLUE in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Monte Rosa Therapeutics, Inc. next reports.
Set alerts on GLUE
Get notified when Monte Rosa Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free